BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 16776574)

  • 1. Adenovirus-mediated and targeted expression of the sodium-iodide symporter permits in vivo radioiodide imaging and therapy of pancreatic tumors.
    Dwyer RM; Bergert ER; O'Connor MK; Gendler SJ; Morris JC
    Hum Gene Ther; 2006 Jun; 17(6):661-8. PubMed ID: 16776574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo radioiodide imaging and treatment of breast cancer xenografts after MUC1-driven expression of the sodium iodide symporter.
    Dwyer RM; Bergert ER; O'connor MK; Gendler SJ; Morris JC
    Clin Cancer Res; 2005 Feb; 11(4):1483-9. PubMed ID: 15746050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo radioiodide imaging and treatment of pancreatic cancer xenografts after MUC1 promoter-driven expression of the human sodium-iodide symporter.
    Chen RF; Li ZH; Pan QH; Zhou JJ; Tang QB; Yu FY; Zhou QB; Wang J; Chen JS
    Pancreatology; 2007; 7(5-6):505-13. PubMed ID: 17912014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium iodide symporter-mediated radioiodide imaging and therapy of ovarian tumor xenografts in mice.
    Dwyer RM; Bergert ER; O'Connor MK; Gendler SJ; Morris JC
    Gene Ther; 2006 Jan; 13(1):60-6. PubMed ID: 16121204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression.
    Spitzweg C; Baker CH; Bergert ER; O'Connor MK; Morris JC
    Hum Gene Ther; 2007 Oct; 18(10):916-24. PubMed ID: 17931047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) gene.
    Schmohl KA; Gupta A; Grünwald GK; Trajkovic-Arsic M; Klutz K; Braren R; Schwaiger M; Nelson PJ; Ogris M; Wagner E; Siveke JT; Spitzweg C
    Oncotarget; 2017 May; 8(20):33393-33404. PubMed ID: 28380420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic image-guided liver cancer radiovirotherapy using dendrimer-coated adenovirus encoding the sodium iodide symporter as theranostic gene.
    Grünwald GK; Vetter A; Klutz K; Willhauck MJ; Schwenk N; Senekowitsch-Schmidtke R; Schwaiger M; Zach C; Wagner E; Göke B; Holm PS; Ogris M; Spitzweg C
    J Nucl Med; 2013 Aug; 54(8):1450-7. PubMed ID: 23843567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of an MUC-1 promoter driven, conditionally replicating adenovirus that expresses the sodium iodide symporter for gene therapy of breast cancer.
    Trujillo MA; Oneal MJ; Davydova J; Bergert E; Yamamoto M; Morris JC
    Breast Cancer Res; 2009; 11(4):R53. PubMed ID: 19635153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated sodium iodide symporter gene delivery.
    Müller AM; Schmohl KA; Knoop K; Schug C; Urnauer S; Hagenhoff A; Clevert DA; Ingrisch M; Niess H; Carlsen J; Zach C; Wagner E; Bartenstein P; Nelson PJ; Spitzweg C
    Oncotarget; 2016 Aug; 7(34):54795-54810. PubMed ID: 27458162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy.
    Kang JH; Chung JK; Lee YJ; Shin JH; Jeong JM; Lee DS; Lee MC
    J Nucl Med; 2004 Sep; 45(9):1571-6. PubMed ID: 15347726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preclinical large animal model of adenovirus-mediated expression of the sodium-iodide symporter for radioiodide imaging and therapy of locally recurrent prostate cancer.
    Dwyer RM; Schatz SM; Bergert ER; Myers RM; Harvey ME; Classic KL; Blanco MC; Frisk CS; Marler RJ; Davis BJ; O'Connor MK; Russell SJ; Morris JC
    Mol Ther; 2005 Nov; 12(5):835-41. PubMed ID: 16054438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy.
    Boland A; Ricard M; Opolon P; Bidart JM; Yeh P; Filetti S; Schlumberger M; Perricaudet M
    Cancer Res; 2000 Jul; 60(13):3484-92. PubMed ID: 10910060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rat sodium iodide symporter allows using lower dose of 131I for cancer therapy.
    Mitrofanova E; Unfer R; Vahanian N; Link C
    Gene Ther; 2006 Jul; 13(13):1052-6. PubMed ID: 16525480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining transfer of TTF-1 and Pax-8 gene: a potential strategy to promote radioiodine therapy of thyroid carcinoma.
    Mu D; Huang R; Li S; Ma X; Lou C; Kuang A
    Cancer Gene Ther; 2012 Jun; 19(6):402-11. PubMed ID: 22498723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A probasin promoter, conditionally replicating adenovirus that expresses the sodium iodide symporter (NIS) for radiovirotherapy of prostate cancer.
    Trujillo MA; Oneal MJ; McDonough S; Qin R; Morris JC
    Gene Ther; 2010 Nov; 17(11):1325-32. PubMed ID: 20428214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of myocardial sodium/iodide symporter gene expression imaging with radioiodide: evaluation with a dual-gene adenovirus vector.
    Lee KH; Kim HK; Paik JY; Matsui T; Choe YS; Choi Y; Kim BT
    J Nucl Med; 2005 Apr; 46(4):652-7. PubMed ID: 15809488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A transporter gene (sodium iodide symporter) for dual purposes in gene therapy: imaging and therapy.
    Cho JY
    Curr Gene Ther; 2002 Dec; 2(4):393-402. PubMed ID: 12477251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter.
    Petrich T; Helmeke HJ; Meyer GJ; Knapp WH; Pötter E
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):842-54. PubMed ID: 12111124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma.
    Ma XJ; Huang R; Kuang AR
    Cancer Invest; 2009 Jul; 27(6):673-81. PubMed ID: 19241193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioiodide treatment after sodium iodide symporter gene transfer is a highly effective therapy in neuroendocrine tumor cells.
    Schipper ML; Weber A; Béhé M; Göke R; Joba W; Schmidt H; Bert T; Simon B; Arnold R; Heufelder AE; Behr TM
    Cancer Res; 2003 Mar; 63(6):1333-8. PubMed ID: 12649195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.